Company intelligence / Profile preview

INSEP

Cambridge, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Insept Therapeutics is a biotechnology company focused on developing next-generation cell therapies for cancer. The company utilizes a proprietary platform to engineer "logic-gated" CAR-T cells, which are designed to improve the precision and safety of immunotherapy by targeting multiple antigens. Founded by industry veterans, Insept aims to overcome the limitations of current CAR-T treatments, such as off-target toxicity and limited efficacy in solid tumors. The company is backed by prominent life science investors and is currently in the pre-clinical stage of development.

Therapeutic areas: Oncology
Modalities: Cell therapyCAR-T cell therapy
Industry: Biotech

Beyond the preview

Go deeper on INSEP.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on INSEP.

Explore the full profile